Marval Biosciences Inc — Form D
Marval Biosciences Inc of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2012-07-26. The offering totals $30.0M, of which $2.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2012-07-26
- Form: D
- Accession: 0001412586-12-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $30.0M
- Amount sold: $2.5M
- Remaining: $27.5M
- Minimum investment: $25K
- Investors: 12
- Security types: equity
- Revenue range: Decline to Disclose
Issuer
- Name: Marval Biosciences Inc
- CIK: 0001412586
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 1441 9TH, SAN DIEGO, CA, 92101-8947
- Phone: 281-802-4776
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Russell Lebovitz | Director | San Diego, CA |
| Russell Lebovitz | Executive Officer | San Diego, CA |
| Dan Watkins | Director | Houston, TX |
| Frank Foster | Director | Santa Barbara, CA |
| Ananth Annapragada | Director | Manvel, TX |
| Ananth Annapragada | Executive Officer | Manvel, TX |
Other filings by this issuer (2)
More